A new meningitis vaccine known as Menactra The Centers for Disease Control and Prevention has recommended that wider use be made of a new meningitis vaccine known as Menactra and manufactured by Sanofi Pasteur. The following categories of young people are the ones the CDC is most interested in seeing vaccinated: all 11- and 12-year-olds; […]
A new meningitis vaccine known as Menactra The Centers for Disease Control and Prevention has recommended that wider use be made of a new meningitis vaccine known as Menactra and manufactured by Sanofi Pasteur. The following categories of young people are the ones the CDC is most interested in seeing vaccinated: all 11- and 12-year-olds; high school freshmen or children under 15, whichever comes earlier, and college freshmen living in dormitories.
Each year about 3,000 people in the United States contract meningococcal disease. About 10% of these people die and another 15% may suffer serious permanent disabilities including loss of hearing, brain damage, or the loss of a limb.
The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).